Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
UBS
Fuji
Harvard Business School
Novartis
Daiichi Sankyo
Teva
Express Scripts
US Army
Chinese Patent Office

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074270

« Back to Dashboard
NDA 074270 describes GEMFIBROZIL, which is a drug marketed by Impax Pharms, Caribe Holdings, Sandoz, Aurobindo Pharma Ltd, Purepac Pharm, Apotex, Invagen Pharms, Sun Pharm Inds Inc, Watson Labs, Mylan, Teva, Cadila Pharms Ltd, Chartwell Molecules, Northstar Hlthcare, and Hikma Pharms, and is included in eighteen NDAs. It is available from forty-nine suppliers. Additional details are available on the GEMFIBROZIL profile page.

The generic ingredient in GEMFIBROZIL is gemfibrozil. Fifty suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.

Summary for NDA: 074270

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074270

Suppliers and Packaging for NDA: 074270

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GEMFIBROZIL
gemfibrozil
TABLET;ORAL 074270 ANDA Blenheim Pharmacal, Inc. 10544-569 10544-569-90 90 TABLET, FILM COATED in 1 BOTTLE (10544-569-90)
GEMFIBROZIL
gemfibrozil
TABLET;ORAL 074270 ANDA PD-Rx Pharmaceuticals, Inc. 55289-411 55289-411-60 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-411-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Sep 27, 1993TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Mallinckrodt
Fuji
McKesson
Merck
Argus Health
Moodys
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot